Perspectives Archives - Page 5 of 5

Basic biotech starter kit: a flourishing ecosystem and highly focused support

“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…

clement08.05.2020

Perspectives

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

Silvio Bonaccio is delighted by the strong entrepreneurial spirit that he encounters in his work as Head of ETH transfer. It took time, effort and…

clement08.05.2020

Perspectives

“The first steps are slow and then suddenly things start rolling”

After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup…

clement06.12.2019

Perspectives

KPMG: Reshaping the future of pharma

From our partner, KPGM: The rules of engagement in the global pharmaceutical industry are changing rapidly with disruption in this industry already well underway. Two…

clement06.12.2019

Perspectives

In the news: From start-ups to the six Swiss exchange – A Swiss success story

Switzerland is consistently ranked the most innovative country in the world, especially when it comes to life sciences. Abi Millar, from Pharma Technology Focus, looks…

clement03.10.2019

Perspectives

Interview with Alex Mayweg, partner at Versant Ventures and president of Ridgeline, a Versant Ventures Discovery Engine

“We make no compromises in creating the highest potential company” Versant Ventures has a strong history in building successful companies such as Therachon, Black Diamond…

clement30.07.2019

Perspectives

Podcast Recap: Interview with George Yancopoulos, President and CSO of Regeneron Pharmaceuticals – “an overnight success story that took 25 years”

Regeneron Pharmaceuticals is one of the biggest biotech success stories. It’s the first biotech in history with 6 marketed drugs, all originated from its own…

clement30.07.2019

Perspectives

UCSF’s interview with Rob Nelson of ARCH Venture Partners

ARCH Venture Partners is behind companies such as Illumina, Alnylam, Unity Biotechnology, Receptos, Agios Pharmaceuticals, Grail, Bluebird, and many more. This interview is part of…

clement24.05.2019

Perspectives

Event Impressions and some Key Quotes: Perfecting Partnerships for Life Sciences Startup Success

Closing a deal is more art than science. This is especially true in the biopharma industry where investments and partnerships are key elements to success.…

clement02.04.2019

Perspectives

Basic biotech starter kit: a flourishing ecosystem and highly focused support

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

“The first steps are slow and then suddenly things start rolling”

KPMG: Reshaping the future of pharma

In the news: From start-ups to the six Swiss exchange – A Swiss success story

Interview with Alex Mayweg, partner at Versant Ventures and president of Ridgeline, a Versant Ventures Discovery Engine

Podcast Recap: Interview with George Yancopoulos, President and CSO of Regeneron Pharmaceuticals – “an overnight success story that took 25 years”

UCSF’s interview with Rob Nelson of ARCH Venture Partners

Event Impressions and some Key Quotes: Perfecting Partnerships for Life Sciences Startup Success

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us